FROM PUBLIC EVENTS · 2026-11-15

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Global approvals · expansion Growing supply to Mexican public procurement while developing a continuous glucose monitor and a point-of-care molecular device. Also seen: Discovery · preclinical

  • Disclosed a supply agreement for HbA1c analysers for Mexican public procurement. Source

Roles often seen at this stageDevice R&D & support · Regulatory affairs · Sales & marketing

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-15

OSANG Healthcare

An in-vitro diagnostics company making blood-glucose meters, HbA1c analysers and test kits, developing a continuous glucose monitor and a point-of-care molecular device.

HbA1c analyser

Marketed

HbA1c analysers and cartridges supplied to Mexico's public procurement market.

Point-of-care molecular diagnostic device

Stage unconfirmed

Point-of-care molecular diagnostic device co-developed with a US company.

Announced

Disclosed a KRW 6.55 billion supply agreement for HbA1c analysers and cartridges for Mexican public procurement.

Official role guide

OSANG Healthcare careers

Current availability unconfirmed

Observed 2026-11-15

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 2

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. 오상헬스케어, 멕시코 정부에 당화혈색소 측정기 대규모 공급 ↗한국경제 · Published 2026-05-13 · Sources checked 2026-11-15 · Original unavailable
  2. 오상헬스케어 "신성장동력 연속혈당측정기·현장분자진단 사업화 집중" ↗머니투데이 · Published 2026-06-22 · Sources checked 2026-11-15 · Original unavailable